Stage IIIC1 Cervical Cancer FIGO 2018
specificCervical carcinoma that involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or para-aortic lymph nodes. (FIGO 2018)
36
Centers
36
Active Trials
—
Cancer Funding
Top Centers for Stage IIIC1 Cervical Cancer FIGO 2018(36)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 51.4 |
| 2 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 51.4 |
| 3 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 51.4 |
| 4 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 51.4 |
| 5 | NCI Comprehensive Active Research Program | 51.4 |
| 6 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 51.4 |
| 7 | NCI Comprehensive Active Research Program | 51.4 |
| 8 | NCI Comprehensive Active Research Program | 51.4 |
| 9 | NCI Comprehensive Active Research Program | 51.4 |
| 10 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 51.4 |
| 11 | NCI Comprehensive Active Research Program | 51.4 |
| 12 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 51.4 |
| 13 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 51.4 |
| 14 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 51.4 |
| 15 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 51.4 |
| 16 | NCI Comprehensive Active Research Program | 51.4 |
| 17 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 51.4 |
| 18 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 51.4 |
| 19 | NCI Clinical Active Research Program | 51.4 |
| 20 | NCI Comprehensive Active Research Program | 51.4 |
| 21 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 51.4 |
| 22 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 51.4 |
| 23 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 51.4 |
| 24 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 51.4 |
| 25 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 51.4 |
| 26 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 51.4 |
| 27 | University of Illinois Cancer CenterChicago, IL Active Research Program | 51.4 |
| 28 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 51.4 |
| 29 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 51.4 |
| 30 | Cancer Center at IllinoisUrbana, IL Active Research Program | 51.4 |
| 31 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 51.4 |
| 32 | Penn State Cancer InstituteHershey, PA Active Research Program | 51.4 |
| 33 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 51.4 |
| 34 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 51.4 |
| 35 | Upstate Cancer CenterSyracuse, NY Active Research Program | 51.4 |
| 36 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 51.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →